Pre-Open Stock Movers:
Tufin (TUFN) 44% HIGHER; Entered into a definitive agreement to be acquired by Turn/River Capital, a software-focused investment firm, in an all-cash transaction that values Tufin at approximately $570 million.
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) 19% HIGHER; The FDA approved IGALMI sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults
Array Technologies Inc. (ARRY) 13% HIGHER; reported Q4 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $219.9 million versus the consensus estimate of $213.82 million. The company sees FY2022 EPS of $0.55-$0.74, versus the consensus of $0.66, and FY2022 revenue of $1.45-1.75 billion, versus the consensus of $1.39 billion.
Tilray (NASDAQ:TLRY), Inc. (TLRY) 13% HIGHER; reported Q3 EPS of $0.09, versus ($1.03) reported last year. Revenue for the quarter came in at $151.9 million, versus $123.9 million reported last year.
Gogo Inc . (NASDAQ:GOGO) 10% HIGHER; picked to replace SPX FLOW in the S&P SmallCap 600.
Cano Health (CANO) 9% LOWER; Piper Sandler downgraded to Underweight as reported results overstated visibility, growth, and profitability.
Avis Budget (NASDAQ:CAR) Group (CAR) 6% LOWER; BofA Securities downgraded to Underperform.
JetBlue Airways (NASDAQ:JBLU) 4% LOWER; confirmed it made a $33/share bid for Spirit Airlines , Inc. (NYSE:SAVE).
Spirit Airlines, Inc. (SAVE) 4% LOWER; Shares consolidate today's 22.4% gains following confirmation that JetBlue Airways made a $33/share bid.
Atreca, Inc. (NASDAQ:BCEL) 3% HIGHER; entered a licensing agreement with Zymework to utilize their ZymeLink technology to develop novel antibody-drug conjugates (ADCs) and declared ATRC-301, an ADC targeting a novel epitope on EphA2, as the Companys next clinical candidate.
Rivian Automotive, Inc. (RIVN) 2% HIGHER; produced 2,553 vehicles and delivered 1,227 during the first quarter, which are in line with the EV companys expectations.